Target Floor Lamp Recall Issued After Fires, Consumer Shocks
Roughly 25,500 floor lamps sold exclusively at Target stores have been recalled after at least six reported incident where the lamps short circuited and caught on fire, resulting in property damage and at least two consumers suffering shocks.
A Target floor lamp recall was announced by the U.S Consumer Product Safety Commission (CPSC) on September 3, after reports of the lamps catching fire when a one-way bulb was fully tightened in the lamp’s three-way socket.
The recall involves 60 inch tall turned-spindle floor lamps with model number PL1071. The lamps are made out of a white plastic and have white fabric drum lamp shades with two 3-way pull chain switches that are illuminated by two 3-way 100 watt or 29 watt CFL bulbs. The model number is located on a sticker at the bottom of the lamp.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The affected lamps were manufactured in China under J. Hunt & Company of Minneapolis, Minnesota were they were sold nationwide at Target Stores and online at target.com only from September 2012 through May 2013 for roughly $70 each.
The CPSC recommends that consumers with the recalled floor lamps immediately stop using and unplug them and return it to any Target store for a full refund. For further question or detail about the recall consumers may contact Target at 800-440-0680 or visit them online at www.target.com and navigate to the “Product Recalls” tab located under the “Help” tab.
"*" indicates required fields
More Top Stories
A ProPublica report reveals that Philips officials hid thousands of reports of problems with sound abatement foam used in millions of CPAP machines, failing to recall the devices for more than a decade after receiving the first complaints.
A Suboxone lawsuit claims the opioid addiction treatment's dental side effects can lead to severe tooth damage and decay.
The FDA is requiring new label warnings to alert patients and doctors to the risk of Ozempic intestinal blockage side effects.